[ARS] BridgeBio Oncology Therapeutics, Inc. SEC Filing Filing Impact (Low) Filing Sentiment (Neutral) Form Type ARS 04/28/2026 - 04:11 PM ⛶ Fullscreen ARS - BridgeBio Oncology Therapeutics, Inc. ARS Filing - BridgeBio Oncology Therapeutics, Inc. This filing is available as a PDF document. Filing Type: ARS Company: BridgeBio Oncology Therapeutics, Inc. (BBOT) Acceptance Date: 2026-04-28T16:11:23.000Z View PDF Document Source: View Original Filing on SEC EDGAR
